debate: is obinutuzumab superior to rituximab in lymphoma? - yes
Published 5 years ago • 2.2K plays • Length 12:52Download video MP4
Download video MP3
Similar videos
-
14:02
debate: is obinutuzumab superior to rituximab in lymphoma? - no
-
17:32
debate: should maintenance rituximab be used in follicular lymphoma? - yes
-
11:42
debate: is watch and wait dead in follicular lymphoma? - yes
-
13:07
debate: a case of stage iv follicular lymphoma - rituximab or "biological doublet" therapy
-
12:45
debate: should maintenance rituximab be used in follicular lymphoma? - no
-
1:32
deciding on rituximab versus obinutuzumab in follicular lymphoma
-
13:41
debate: best upfront therapy for advanced follicular lymphoma - obinutuzumab-based therapy
-
9:21
debate: a case of stage i follicular lymphoma - radiation /- systemic treatment
-
1:23:49
immune 83: immune cells eating other cells
-
13:16
the immune system vs. cancer | jedd wolchok | tedxtimessquare
-
55:33
polarix lymphoma trial debate
-
21:17
new anti-cd20 antibodies for cll - are they better than rituximab?
-
22:46
follicular lymphoma debate: does chemotherapy have a major role to play?
-
2:20
cll whiteboard #2: mechanisms of action of anti-cd20 agents
-
40:12
monoclonal antibodies – rituximab & obinutuzumab | rebecca beck, lymphoma australia
-
11:22
debate: follicular lymphoma - do not treat
-
2:57
costs of venetoclax-obinutuzumab vs. btki in cll | scott huntington, md, mph, msc | ash 2023
-
4:34
obinutuzumab bests rituximab for pfs in follicular lymphoma
-
19:11
is there long term benefit from maintenance rituximab for lymphoma patients?
-
12:40
debate: a case of stage iv follicular lymphoma - r-chop or b-r
-
6:55
robert e. marcus, md: gallium study of obinutuzumab in untreated follicular lymphoma
-
6:20
frontline treatment for follicular lymphoma